Article (Scientific journals)
A phase I trial on LBH 589 (panobinostat), a histone deacetylase inhibitor (HDAC i) in combination with external radiotherapy for the treatment of prostate cancer, esophageal cancer and head and neck cancer.
Coucke, Philippe
2009In Belgian Journal of Medical Oncology, 3 (3), p. 121
Peer Reviewed verified by ORBi
 

Files


Full Text
A phase I trial on LBH 589 (panobinostat), a histone deacetylase inhibitor (HDAC i) in combination with external radiotherapy for the treatment of prostate cancer, esophageal cancer and head and neck cancer..pdf
Publisher postprint (264.92 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Oncology
Author, co-author :
Coucke, Philippe  ;  Université de Liège - ULiège > Radiothérapie
Language :
English
Title :
A phase I trial on LBH 589 (panobinostat), a histone deacetylase inhibitor (HDAC i) in combination with external radiotherapy for the treatment of prostate cancer, esophageal cancer and head and neck cancer.
Publication date :
2009
Journal title :
Belgian Journal of Medical Oncology
ISSN :
1784-7141
Publisher :
Ariez Medical Publishing, Amsterdam, Netherlands
Volume :
3
Issue :
3
Pages :
121
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 25 February 2010

Statistics


Number of views
75 (1 by ULiège)
Number of downloads
100 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi